Cargando…

Stem cells for bronchopulmonary dysplasia in preterm infants: A randomized controlled phase II trial

We previously demonstrated the safety and feasibility of mesenchymal stem cell (MSC) transplantation for bronchopulmonary dysplasia (BPD) in preterm infants in a phase I clinical trial. We thus investigated the therapeutic efficacy of MSCs for BPD in premature infants. A phase II double‐blind, rando...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, So Yoon, Chang, Yun Sil, Lee, Myung Hee, Sung, Se In, Lee, Byong Sop, Kim, Ki Soo, Kim, Ai‐Rhan, Park, Won Soon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Human Clinical Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284779/ https://www.ncbi.nlm.nih.gov/pubmed/33876883 http://dx.doi.org/10.1002/sctm.20-0330

Ejemplares similares

Trends in Survival and Incidence of Bronchopulmonary Dysplasia in Extremely Preterm Infants at 23–26 Weeks Gestation
por: Kim, Jin Kyu, et al.
Publicado: (2016)

Early pulmonary hypertension is a risk factor for bronchopulmonary dysplasia-associated late pulmonary hypertension in extremely preterm infants
por: Kim, Hyun Ho, et al.
Publicado: (2021)

Pulmonary Hypertension in Preterm Infants With Bronchopulmonary Dysplasia
por: An, Hyo Soon, et al.
Publicado: (2010)

Mesenchymal Stem Cells for Severe Intraventricular Hemorrhage in Preterm Infants: Phase I Dose‐Escalation Clinical Trial
por: Ahn, So Yoon, et al.
Publicado: (2018)

Stem Cell Therapy for Bronchopulmonary Dysplasia: Bench to Bedside Translation
por: Ahn, So Yoon, et al.
Publicado: (2015)

Validity of the Ages and Stages Questionnaires in Korean Compared to Bayley Scales of Infant Development-II for Screening Preterm Infants at Corrected Age of 18-24 Months for Neurodevelopmental Delay
por: Kwun, Yoojin, et al.
Publicado: (2015)

Late-Onset Sepsis as a Risk Factor for Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants: A Nationwide Cohort Study
por: Jung, Euiseok, et al.
Publicado: (2019)

Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
por: Rivera, Lidys, et al.
Publicado: (2016)

A Case of Campomelic Dysplasia without Sex Reversal
por: Kim, Hyoung-Young, et al.
Publicado: (2011)

Comparison of definitions of bronchopulmonary dysplasia to reflect the long-term outcomes of extremely preterm infants
por: Jeon, Ga Won, et al.
Publicado: (2022)

Plasma B-type natriuretic peptide cannot predict treatment response to ibuprofen in preterm infants with patent ductus arteriosus
por: Oh, Seong Hee, et al.
Publicado: (2020)

Validity of the Korean Developmental Screening Test for very-low-birth-weight infants
por: Kim, Chae Young, et al.
Publicado: (2019)

Nutrition of preterm infants in relation to bronchopulmonary dysplasia
por: Wemhöner, Andreas, et al.
Publicado: (2011)

Vitamin D and bronchopulmonary dysplasia in preterm infants
por: Joung, K E, et al.
Publicado: (2016)

Definitions of bronchopulmonary dysplasia and long-term outcomes of extremely preterm infants in Korean Neonatal Network
por: Jeon, Ga Won, et al.
Publicado: (2021)

Risk Factors for Tracheobronchomalacia in Preterm Infants With Bronchopulmonary Dysplasia
por: Su, Ya-Ting, et al.
Publicado: (2021)

Right Atrial Strain in Preterm Infants With a History of Bronchopulmonary Dysplasia
por: Kang, Soo Jung, et al.
Publicado: (2022)

Survival and Morbidities in Infants with Birth Weight Less than 500 g: a Nationwide Cohort Study
por: Hwang, Ji Hye, et al.
Publicado: (2021)

Prevention of human milk-acquired cytomegalovirus infection in very-low-birth-weight infants
por: Chung, Mi Lim, et al.
Publicado: (2023)

Initial respiratory management in preterm infants and bronchopulmonary dysplasia
por: López, Ester Sanz, et al.
Publicado: (2011)

Association between anemia and bronchopulmonary dysplasia in preterm infants
por: Duan, Jun, et al.
Publicado: (2016)

Evidence for the Management of Bronchopulmonary Dysplasia in Very Preterm Infants
por: Muehlbacher, Tobias, et al.
Publicado: (2021)

Association between probiotics and bronchopulmonary dysplasia in preterm infants
por: Qu, Yangming, et al.
Publicado: (2021)

Respiratory Tract Microecology and Bronchopulmonary Dysplasia in Preterm Infants
por: Sun, Tong, et al.
Publicado: (2021)

The nasal microbiome of predicting bronchopulmonary dysplasia in preterm infants
por: Xu, Yanping, et al.
Publicado: (2022)

Morbidity and Mortality of Very Low Birth Weight Infants with Congenital Heart Disease
por: Song, Woo Sun, et al.
Publicado: (2020)

Interstitial pneumonia pattern on day 7 chest radiograph predicts bronchopulmonary dysplasia in preterm infants
por: Kim, Hye-Rim, et al.
Publicado: (2017)

Effect of Nonintervention vs Oral Ibuprofen in Patent Ductus Arteriosus in Preterm Infants: A Randomized Clinical Trial
por: Sung, Se In, et al.
Publicado: (2020)

Ceramides in tracheal aspirates of preterm infants: Marker for bronchopulmonary dysplasia
por: van Mastrigt, Esther, et al.
Publicado: (2018)

Airway nitrite is increased in extremely preterm infants with bronchopulmonary dysplasia
por: Gentle, Samuel J., et al.
Publicado: (2020)

The Correlation Between Bronchopulmonary Dysplasia and Platelet Metabolism in Preterm Infants
por: Yan, Longli, et al.
Publicado: (2021)

The Change of Cytokines and Gut Microbiome in Preterm Infants for Bronchopulmonary Dysplasia
por: Zhang, Zhenjie, et al.
Publicado: (2022)

Postnatal steroid management in preterm infants with evolving bronchopulmonary dysplasia
por: Htun, Zeyar T., et al.
Publicado: (2021)

Risk prediction of bronchopulmonary dysplasia in preterm infants by the nomogram model
por: Gao, Yang, et al.
Publicado: (2023)

Two‐year outcomes of infants enrolled in the first‐in‐human study of amnion cells for bronchopulmonary dysplasia
por: Malhotra, Atul, et al.
Publicado: (2019)

Effect of Prophylactic Palivizumab on Admission Due to Respiratory Syncytial Virus Infection in Former Very Low Birth Weight Infants with Bronchopulmonary Dysplasia
por: Han, Young Mi, et al.
Publicado: (2015)

First‐In‐Human Administration of Allogeneic Amnion Cells in Premature Infants With Bronchopulmonary Dysplasia: A Safety Study
por: Lim, Rebecca, et al.
Publicado: (2018)

Pulmonary hypertension in infants with bronchopulmonary dysplasia
por: Kim, Gi Beom
Publicado: (2010)

Carboxyhemoglobin Formation in Preterm Infants Is Related to the Subsequent Development of Bronchopulmonary Dysplasia
por: Tokuriki, Shuko, et al.
Publicado: (2015)

Increased Regulatory T Cells Precede the Development of Bronchopulmonary Dysplasia in Preterm Infants
por: Pagel, Julia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o3sqsnklvjoj0jads5ojrvvdtq